Comparison of Paliperidone Palmitate and Risperidone Long-Acting Injection in Schizophrenic Patients: Results From a Multicenter Retrospective Cohort Study in France

PURPOSE/BACKGROUND: The study objective was to compare the impact of being treated by paliperidone palmitate (PP) or risperidone long-acting injection (RLAI) on the length of stay on initial hospitalization, rehospitalization risk, and treatment duration in schizophrenic patients. METHODS: We conduc...

Descripción completa

Detalles Bibliográficos
Autores principales: Limosin, Frédéric, Belhadi, Drifa, Comet, Denis, Pacou, Maud, Bouju, Sophie, Van Impe, Kristel, Guillon, Pascal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737453/
https://www.ncbi.nlm.nih.gov/pubmed/29232310
http://dx.doi.org/10.1097/JCP.0000000000000827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737453/
https://www.ncbi.nlm.nih.gov/pubmed/29232310
http://dx.doi.org/10.1097/JCP.0000000000000827

Ejemplares similares